World Health Organization. WHO guideline on country pharmaceutical pricing policies. World Health Organization; 2015.

Mhlanga BS, Suleman F. Price, availability and affordability of medicines. Afr J Prim Health Care Fam Med. 2014;6(1):1–6.

Article  Google Scholar 

Vogler S, Kilpatrick K. Analysis of medicine prices in New Zealand and 16 European countries. Value Health. 2015;18(4):484–92.

Article  PubMed  Google Scholar 

Zaprutko T, Kopciuch D, Kus K, Merks P, Nowicka M, Augustyniak I, Nowakowska E. Affordability of medicines in the European Union. PLoS ONE. 2017;12(2): e0172753.

Article  PubMed  PubMed Central  Google Scholar 

Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240–9.

Article  CAS  PubMed  Google Scholar 

Raghfar H, Sargazi N, Mehraban S, Akbarzadeh MA, VaezMahdavi MR, VahdatiManesh Z. The economic burden of coronary heart disease in Iran: a bottom-up approach in 2014. J Ardabil Univ Med Sci. 2018;18(3):341–56.

Article  Google Scholar 

Darba S, Safaei N, Mahboub-Ahari A, Nosratnejad S, Alizadeh G, Ameri H, Yousefi M. Direct and Indirect Costs Associated with Coronary Artery (Heart) Disease in Tabriz, Iran. Risk Manag Healthcare Policy. 2020;13:969.

Article  Google Scholar 

Members WG, Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–220.

Google Scholar 

Organization WH. Prevention of recurrent heart attacks and strokes in low and middle income populations: evidence-based recommendations for policy-makers and health professionals. World Health Organization; 2003.

Evaluation IfHMa. https://vizhub.healthdata.org/gbd-compare/. Accessed 11 July 2022.

Mendis S, Fukino K, Cameron A, Laing R, Filipe A Jr, Khatib O, Leowski J, Ewen M. The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries. Bull World Health Organ. 2007;85:279–88.

Article  PubMed  PubMed Central  Google Scholar 

van Mourik MS, Cameron A, Ewen M, Laing RO. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data. BMC Cardiovasc Disord. 2010;10(1):1–9.

Google Scholar 

Afghanistan MoPHo. Afghanistan Pharmaceutical Country Profile. 2011. https://www.who.int/medicines/areas/coordination/AfghanistanPSCPnarrative.pdf. Accessed 11 July 2022.

Abdelrahiem SK, Bilal JA, Al Nafeesah A, Al-Wutayd O, Rayis DA, Adam I. Low and high birth weight in a hospital population in Sudan: An analysis of clinical cut-off values. Int J Gynaecol Obstet. 2021;154(3):427–30.

Article  PubMed  Google Scholar 

Heidari E, Varmaghani M, Abdollahiasl A. Availability, pricing and affordability of selected medicines for noncommunicable diseases. East Mediterr Health J. 2019;25(7):473–80.

Article  PubMed  Google Scholar 

Madden JM, Meza E, Ewen M, Laing RO, Stephens P, Ross-Degnan D. Measuring medicine prices in Peru: validation of key aspects of WHO/HAI survey methodology. Rev Panam Salud Publica. 2010;27:291–9.

Article  PubMed  Google Scholar 

Jiang M, Yang S, Yan K, Liu J, Zhao J, Fang Y. Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi province of China. PLoS ONE. 2013;8(8): e70836.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kotwani A. Medicine prices, availability, affordability and medicine price components in NCT, Delhi: WHO/HAI methodology. 2011.

Raju PKS. WHO/HAI methodology for measuring medicine prices, availability and affordability, and price components. In: Medicine price surveys, analyses and comparisons. Academic Press; 2019:209–228.

Farahani AV, Salamzadeh J, Rasekh HR, Najafi S, Mosadegh V. The availability and affordability of cardiovascular medicines for secondary prevention in tehran province (Iran). Iran J Pharm Res: IJPR. 2018;17(Suppl):64.

Google Scholar 

Organization. WH. Afghanistan. 2015. https://applications.emro.who.int/dsaf/EMROPUB_2016_EN_18925.pdf?ua=18921. Accessed 11 July 2022.

Paterson A, Karimi A. Understanding markets in Afghanistan: a study of the market for pharmaceuticals. Afghanistan Research and Evaluation Unit Kabul; 2005.

Kokabisaghi F. Right to Health; the Application of International Laws in the Islamic Republic of Iran. Erasmus University Rotterdam; 2019. Retrieved from http://hdl.handle.net/1765/116524.

Iyengar S, Tay-Teo K, Vogler S, Beyer P, Wiktor S, de Joncheere K, Hill S. Prices, costs, and affordability of new medicines for hepatitis C in 30 countries: an economic analysis. PLoS Med. 2016;13(5): e1002032.

Article  PubMed  PubMed Central  Google Scholar